BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31283668)

  • 41. Perioperative prostaglandin e1 infusion in living donor liver transplantation: A double-blind, placebo-controlled randomized trial.
    Bharathan VK; Chandran B; Gopalakrishnan U; Varghese CT; Menon RN; Balakrishnan D; Sudheer OV; Dhar P; Surendran S
    Liver Transpl; 2016 Aug; 22(8):1067-74. PubMed ID: 27152759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endothelial glycocalyx damage in kidney disease correlates with uraemic toxins and endothelial dysfunction.
    Liew H; Roberts MA; Pope A; McMahon LP
    BMC Nephrol; 2021 Jan; 22(1):21. PubMed ID: 33423673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation.
    Kollmann D; Sapisochin G; Goldaracena N; Hansen BE; Rajakumar R; Selzner N; Bhat M; McCluskey S; Cattral MS; Greig PD; Lilly L; McGilvray ID; Ghanekar A; Grant DR; Selzner M
    Liver Transpl; 2018 Jun; 24(6):779-789. PubMed ID: 29604237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.
    Olthoff KM; Kulik L; Samstein B; Kaminski M; Abecassis M; Emond J; Shaked A; Christie JD
    Liver Transpl; 2010 Aug; 16(8):943-9. PubMed ID: 20677285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Endothelial Glycocalyx and Organ Preservation-From Physiology to Possible Clinical Implications for Solid Organ Transplantation.
    Mathis S; Putzer G; Schneeberger S; Martini J
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma Ameliorates Endothelial Dysfunction in Burn Injury.
    Vigiola Cruz M; Carney BC; Luker JN; Monger KW; Vazquez JS; Moffatt LT; Johnson LS; Shupp JW
    J Surg Res; 2019 Jan; 233():459-466. PubMed ID: 30502286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver disease.
    Huang C; Huang S; Tang Y; Zhao Q; Wang D; Ju W; Yang L; Zhang J; Wu L; Chen M; Zhang Z; Zhu Z; Wang L; Zhu C; Zhang Y; Sun C; Xiong W; Shen Y; Chen X; Ma Y; Hu A; Zhu X; Rong J; Cai C; Guo Z; He X
    BMJ Open; 2020 May; 10(5):e035374. PubMed ID: 32376754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Controlled Oxygenated Rewarming of Cold Stored Livers Prior to Transplantation: First Clinical Application of a New Concept.
    Hoyer DP; Mathé Z; Gallinat A; Canbay AC; Treckmann JW; Rauen U; Paul A; Minor T
    Transplantation; 2016 Jan; 100(1):147-52. PubMed ID: 26479280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycocalyx Degradation and Inflammation in Cardiac Surgery.
    Pesonen E; Passov A; Andersson S; Suojaranta R; Niemi T; Raivio P; Salmenperä M; Schramko A
    J Cardiothorac Vasc Anesth; 2019 Feb; 33(2):341-345. PubMed ID: 29724540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postreperfusion microcirculatory derangements after liver transplantation: Relationship to hemodynamics, serum mediators, and outcome.
    Pulitano C; Joseph D; Sandroussi C; Verran D; Ho P; Debiasio A; Luongo A; McCaughan GW; Shackel NA; Crawford M
    Liver Transpl; 2017 Apr; 23(4):527-536. PubMed ID: 28073175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heparanase inhibition preserves the endothelial glycocalyx in lung grafts and improves lung preservation and transplant outcomes.
    Noda K; Philips BJ; Snyder ME; Phillippi JA; Sullivan M; Stolz DB; Ren X; Luketich JD; Sanchez PG
    Sci Rep; 2021 Jun; 11(1):12265. PubMed ID: 34112915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Graft Regeneration and Functional Recovery in Patients with Early Allograft Dysfunction After Living-Donor Liver Transplantation.
    Chae MS; Kim Y; Lee N; Chung HS; Park CS; Lee J; Choi JH; Hong S
    Ann Transplant; 2018 Jul; 23():481-490. PubMed ID: 30013021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of glycine in dog and rat liver transplantation.
    den Butter G; Lindell SL; Sumimoto R; Schilling MK; Southard JH; Belzer FO
    Transplantation; 1993 Oct; 56(4):817-22. PubMed ID: 8212199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. First Comparison of Hypothermic Oxygenated PErfusion Versus Static Cold Storage of Human Donation After Cardiac Death Liver Transplants: An International-matched Case Analysis.
    Dutkowski P; Polak WG; Muiesan P; Schlegel A; Verhoeven CJ; Scalera I; DeOliveira ML; Kron P; Clavien PA
    Ann Surg; 2015 Nov; 262(5):764-70; discussion 770-1. PubMed ID: 26583664
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver Retransplantation Associated With Kidney Transplantation for End-stage Liver Graft Disease and Renal Insufficiency: A Morbid Procedure on a Unique Subgroup of Patients.
    Cauchy F; Vibert E; Cherqui D; Perdigao F; Sepulveda A; Samuel D; Calmus Y; Conti F; Adam R; Soubrane O; Scatton O
    Transplantation; 2020 Jul; 104(7):1403-1412. PubMed ID: 31651789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score.
    Wagener G; Raffel B; Young AT; Minhaz M; Emond J
    Liver Transpl; 2013 May; 19(5):534-42. PubMed ID: 23576469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C-positive recipients.
    Martini S; Tandoi F; Terzi di Bergamo L; Strona S; Lavezzo B; Sacco M; Maione F; Gonella F; Strignano P; Dell Olio D; Salizzoni M; Saracco GM; Romagnoli R
    Liver Transpl; 2017 Jul; 23(7):915-924. PubMed ID: 28422425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients.
    Ito T; Naini BV; Markovic D; Aziz A; Younan S; Lu M; Hirao H; Kadono K; Kojima H; DiNorcia J; Agopian VG; Yersiz H; Farmer DG; Busuttil RW; Kupiec-Weglinski JW; Kaldas FM
    Am J Transplant; 2021 Feb; 21(2):614-625. PubMed ID: 32713098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recipient Selection for Optimal Utilization of Discarded Grafts in Liver Transplantation.
    Giretti G; Barbier L; Bucur P; Marques F; Perarnau JM; Ferrandière M; Tellier AC; Kerouredan V; Altieri M; Causse X; Debette-Gratien M; Silvain C; Salamé E
    Transplantation; 2018 May; 102(5):775-782. PubMed ID: 29298235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycocalyx Preservation and NO Production in Fatty Livers-The Protective Role of High Molecular Polyethylene Glycol in Cold Ischemia Injury.
    Lopez A; Panisello-Rosello A; Castro-Benitez C; Adam R
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.